Top in cardiology: Advances in cardiometabolic care, CVD risk in women

A keynote speech at the virtual Cardiometabolic Health Congress focused on advances in the use of genetics, artificial intelligence and SGLT2 inhibitors in cardiometabolic care. It was the top story in cardiology last week.

Another top story was about a study that showed certain reproductive profiles in women may indicate an increased risk for CVD.

Read these and more top stories in cardiology below:

Braunwald: ‘Striking’ advances made in cardiometabolic care

During his keynote discussion, Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine at Harvard Medical School and founding chairman of the TIMI Study Group at Brigham and Women’s Hospital, discussed recent advances in cardiometabolic care and how they may apply to clinical practice in the future. Read more.

Reproductive profiles in women may indicate future CVD risk

Several reproductive factors, including preeclampsia, preterm birth and early menopause, may increase risk for CVD in women, researchers found. Read more.

New AHA guidance on CPR, emergency CV care ‘a synthesis of important science’

The American Heart Association announced new guidance and updates to prior recommendations for the 2020 guidelines for CPR and emergency cardiovascular care, according to a publication in Circulation. Read more.

Deprescribing CV medications may benefit elderly patients with evolving treatment goals

In recent years, there has been increased emphasis on deprescribing strategies for patients near the end of their lives who are taking a large number of medications, which can be difficult to manage on a day-to-day basis. Read more.

Racial, ethnic health disparities, already prevalent, growing worse due to COVID-19

Health equity and acknowledgment of disparities among Black and Hispanic individuals is of paramount concern, especially amid the COVID-19 pandemic, according to a presentation at the virtual Cardiometabolic Health Congress. Read more.